Ohcanbohtosat - Hung V.‐T. Nguyen
- Čájehuvvo 1 - 4 / 4
-
1
Using an RNAi Signature Assay To Guide the Design of Three-Drug-Conjugated Nanoparticles with Validated Mechanisms, In Vivo Efficacy, and Low Toxicity Dahkki Jonathan C. Barnes, Peter M. Bruno, Hung V.‐T. Nguyen, Longyan Liao, Jenny Liu, Michael T. Hemann, Jeremiah A. Johnson
Almmustuhtton 2016Artigo -
2
Molecular bottlebrush prodrugs as mono- and triplex combination therapies for multiple myeloma Dahkki Alexandre Detappe, Hung V.‐T. Nguyen, Yivan Jiang, Michael P. Agius, Wencong Wang, C. Mathieu, Nang Kham Su, Samantha L. Kristufek, David Lundberg, Sachin Bhagchandani, Irene M. Ghobrial, P. Peter Ghoroghchian, Jeremiah A. Johnson
Almmustuhtton 2023Artigo -
3
Synthetic Glycomacromolecules of Defined Valency, Absolute Configuration, and Topology Distinguish between Human Lectins Dahkki Manuel Hartweg, Yivan Jiang, Gökhan Yilmaz, Cassie M. Jarvis, Hung V.‐T. Nguyen, Gastón A. Primo, Alessandra Monaco, Valentin P. Beyer, Kathleen K. Chen, Somesh Mohapatra, Simon Axelrod, Rafael Gómez‐Bombarelli, Laura L. Kiessling, C. Remzi Becer, Jeremiah A. Johnson
Almmustuhtton 2021Artigo -
4
Engineering kinetics of TLR7/8 agonist release from bottlebrush prodrugs enables tumor-focused immune stimulation Dahkki Sachin Bhagchandani, Farrukh Vohidov, Lauren E. Milling, Yuzhou Evelyn Tong, Christopher M. Brown, Michelle L. Ramseier, Bin Liu, Timothy Fessenden, Hung V.‐T. Nguyen, Gavin R. Kiel, Lori Won, Róbert Langer, Stefani Spranger, Alex K. Shalek, Darrell J. Irvine, Jeremiah A. Johnson
Almmustuhtton 2023Artigo
Ohcanreaiddut:
Laktáseaddji fáttát
Biology
Biochemistry
Chemistry
Medicine
Pharmacology
Prodrug
Biotechnology
Drug
Immune system
In vivo
Internal medicine
Organic chemistry
Agonist
Antigen
Binding selectivity
Binding site
Bortezomib
C-type lectin
Cancer
Chemotherapy
Cisplatin
Colorectal cancer
Combination therapy
Combinatorics
Context (archaeology)
DC-SIGN
Dendritic cell
Drug action
Drug delivery
Epitope